Peter Fitzgerald Ph.D Overview

  • Primary Position
  • Chief Medical Of...

  • Primary Industry
  • Healthcare

  • Active Board Seats
  • 6

  • Med. Deal Size

  • Med. Valuation

Peter Fitzgerald Ph.D General Information

Biography

Dr. Peter Fitzgerald serves as Chief Medical Officer & Member of the Scientific Advisory Board at HeartBeam. He is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. He is an interventional cardiologist and holds a PhD in Electrical Engineering. He is a Professor Emeritus in the Department of Medicine (Cardiology) at Stanford University. Over the past two decades, he has trained post-doctoral candidates in engineering and medicine. He served as a Medical Venture Partner at BioStar Capital. He has been the principal and Founder of 24 medical device companies in the San Francisco Bay area, transitioning 18 of these start-ups to medium/large-cap life science companies. In 2009, he co-founded TriVentures, an Israeli-based incubator/venture fund for early-stage medical technology and digital health. He has also been a consultant to the US Food and Drug Administration for the past 20 years, focused on medical technology and data-driven health analytics.

Contact Information

Primary Position
Chief Medical Officer & Member of Scientific Advisory Board, HeartBeam
Education
Stanford University, RA
Dartmouth College, Ph.D. (Doctor of Philosophy)
Rensselaer Polytechnic, MS (Master of Science)
Dartmouth College, MD (Doctor of Medicine)
University of Virginia, Degree
Santa Clara University, BS (Bachelor of Science)
Gender
Male
Email
pe
Phone
+1 (408)
Address
  • 2118 Walsh Avenue
  • Suite 210
  • Santa Clara, CA 95050
  • United States
+1 (408)

Peter Fitzgerald Ph.D Positions (5)

Firm name Firm type Title Location Industry Since
HeartBeam Company Chief Medical Officer & Member of Scientific Advisory Board Santa Clara, CA Diagnostic Equipment
Latterell Venture Partners Investor Venture Consultant San Ramon, CA Venture Capital
PNI Digital Media Company Chairman Vancouver, Canada Business/Productivity Software
TransPacific Venture Partners Investor Managing Director Taipei City, Taiwan Venture Capital
Triventures Investor Co-Founder & Managing Partner Herzliya, Israel Venture Capital

Peter Fitzgerald Ph.D Board Seats (6)

Company Industry Ownership Status Financing Status Location Since
19Labs Diagnostic Equipment Privately Held (backing) Venture Capital-Backed Redwood City, CA
Colospan Surgical Devices Privately Held (backing) Venture Capital-Backed Kfar Saba, Israel
Day Zero Diagnostics Diagnostic Equipment Privately Held (backing) Venture Capital-Backed Boston, MA
Genoox Enterprise Systems (Healthcare) Privately Held (backing) Private Equity-Backed Palo Alto, CA
PNI Digital Media Business/Productivity Software Acquired/Merged (Operating Subsidiary) Formerly VC-backed Vancouver, Canada

Peter Fitzgerald Ph.D Lead Partner on Deals (24)

Company Deal Date Deal Type Deal Size Deal Status Industry Location
Day Zero Diagnostics 09-Feb-2022 Later Stage VC (Series A1) Completed Diagnostic Equipment Boston, MA
Genoox 01-May-2021 Completed Enterprise Systems (Healthcare) Palo Alto, CA
V-Wave 22-Sep-2020 Completed Therapeutic Devices Caesarea, Israel
Cala Health 21-May-2019 Completed Therapeutic Devices San Mateo, CA
CathWorks 04-Feb-2019 Completed Decision/Risk Analysis Kfar-Saba, Israel
Day Zero Diagnostics 20-Dec-2018 Completed Diagnostic Equipment Boston, MA
Somnics 02-Oct-2018 Completed Therapeutic Devices Zhubei, Taiwan
19Labs 04-Jun-2018 Completed Diagnostic Equipment Redwood City, CA
Genoox 15-May-2018 Early Stage VC (Series B) Completed Enterprise Systems (Healthcare) Palo Alto, CA
CathWorks 02-Oct-2017 Early Stage VC (Series B) Completed Decision/Risk Analysis Kfar-Saba, Israel

Peter Fitzgerald Ph.D Network (158)

Board Members (73)

Name Company Representing Location From
Scott Ward Apica Cardiovascular Self Galway, Ireland
Scott Ward CathWorks Self Kfar-Saba, Israel
Colospan Clal Biotechnology Industries Kfar Saba, Israel
Stem Cell Theranostics Self Redwood City, CA
OrthoSpace HealthpointCapital Caesarea, Israel

Portfolio Executives (70)

Name Company Role Deal date Location
Jeremy Parrish Day Zero Diagnostics Senior Director of Finance & Operations 09-Feb-2022 Boston, MA
Dougal Maclaurin Ph.D Day Zero Diagnostics Scientific Co-Founder 09-Feb-2022 Boston, MA
Day Zero Diagnostics Scientific Co-founder 09-Feb-2022 Boston, MA
Day Zero Diagnostics Co-Founder & Chief Technology Officer 09-Feb-2022 Boston, MA
Day Zero Diagnostics Co-Founder & Chief Scientific Officer 09-Feb-2022 Boston, MA

Fund Team Members (15)

Name Investor Fund Fund Location
Orli Tori Triventures Triventures IV Fund Herzliya, Israel
Stephen Salmon Latterell Venture Partners Latterell Venture Partners III San Ramon, CA
Latterell Venture Partners San Ramon, CA
BioStar Capital Charlevoix, MI
BioStar Capital Charlevoix, MI

Peter Fitzgerald Ph.D Affiliated Funds (6)

Fund Investor Fund Type Status Vintage Size Dry Powder IRR IRR Quartile
BioStar Ventures II BioStar Capital Venture - General Closed 2008
Triventures III Fund Triventures Venture - General Closed 2015
BioStar Ventures III BioStar Capital Venture - General Closed 2013
Triventures IV Fund Triventures Venture - General Closed 2019
TransPacific Medtech Fund TransPacific Venture Partners Venture - General Closed 2014

Peter Fitzgerald Ph.D Advisory Roles (1)

Firm name Firm type Title Location Industry Since
Teal Ventures Investor Advisor San Diego, CA Venture Capital

Peter Fitzgerald Ph.D FAQs

  • Who is Peter Fitzgerald Ph.D?

    Dr. Peter Fitzgerald serves as Chief Medical Officer & Member of the Scientific Advisory Board at HeartBeam.

  • How much does Peter Fitzgerald Ph.D typically invest?

    Peter Fitzgerald Ph.D's median deal size is .

  • What is Peter Fitzgerald Ph.D’s main position?

    Peter Fitzgerald Ph.D’s primary position is Chief Medical Officer & Member of Scientific Advisory Board.

  • What are the contact details for Peter Fitzgerald Ph.D?

    Peter Fitzgerald Ph.D’s email address is pe and his phone number is +1 (408) .

  • How many active board seats does Peter Fitzgerald Ph.D hold?

    Peter Fitzgerald Ph.D holds 6 board seats including 19Labs, Colospan, Day Zero Diagnostics, Genoox, and PNI Digital Media.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »